Stay updated on Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and an old government-funding/operating-status notice was deleted.
    Difference
    0.6%
    Check dated 2026-02-11T14:29:31.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, and the revision history now shows v3.4.1 replacing v3.4.0. These updates are informational and do not affect study details, results, or user interactions; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-04T10:42:58.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI enhancements to the history view include a Show glossary option and color-coded highlights for additions and deletions, along with updated revision labels (v3.4.0). These changes affect presentation only and do not modify the trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-01-28T06:20:52.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4; no substantive changes to study history or page content.
    Difference
    0.1%
    Check dated 2026-01-14T02:11:00.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    - Added a new revision note 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T21:48:13.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    New sections Adverse Events, Outcome Measures, Participant Flow, Contacts/Locations, and Study Status were added in versions dated 2025-11-23 and 2025-12-11; a prior entry dated 2024-11-21 was removed.
    Difference
    0.7%
    Check dated 2025-12-16T20:57:23.000Z thumbnail image

Stay in the know with updates to Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.